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ABSTRACT 
Background: Myotonic dystrophy type 1 (DM1) is a neuromuscular multi-
systemic disorder with slowly progressive muscle weakness. The overall 
purpose of this thesis was, in adult patients with DM1, to investigate factors 
of importance for functional balance skills and falls, and to investigate the 
natural course of muscle force and functional balance impairments, with 
reliable measurement methods. 
Methods: In the first study we evaluated test-retest reliability in static and 
dynamic balance tests and gait, with three assessment occasions spaced one-
week apart, in ten patients with DM1. In the second study, which is a cross-
sectional study, 51 patients were assessed for muscle strength, gait and 
functional balance together with self-reported balance confidence, walking 
ability and falls. A multivariate analysis of factors of importance for 
functional balance impairment was performed. Of these 51 patients, 43 were 
further analysed in a third five-year prospective study for changes in muscle 
force, gait and functional balance together with self-reported balance 
confidence, walking ability and falls. 
Results: The test-retest reliability analysis results advocate dynamic balance 
tests and timed gait before the static tests. The cross-sectional study shows 
that falls are common in the weaker, but still ambulant, patients. A 
combination of weak ankle muscles and a physical capability to accelerate to 
fast walking increased the risk of falling. Over five years the distal muscles 
of the leg have a more steep force decrease than the proximal muscles. There 
was a tendency towards a greater worsening in males, and we found a 
statistically significant difference between genders in the knee extensor and 
flexor force change. All men had fallen within the previous year at the five-
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flexor force change. All men had fallen within the previous year at the five-
year assessment. Injuries of the face and head were more frequent at five 
years. 
Conclusions: Test-retest reliable dynamic balance tests and isometric 
muscle force measures showed that there is a statistically significant 
decrease in functional balance skill and in leg muscle force after five years in 
patients with DM1. The number of patients who had fallen had increased and 
the fall injuries were worse. It is of great importance to prevent falls 
especially in those who are at most risk for falls, by which we mean those 
who have a more steep muscle force reduction. Regular assessments of gait, 
functional balance and leg muscle force could be a way to determine who is 
at most risk for falls. This would give the opportunity to intervene with 
rehabilitation therapy and assistive devices as possible means for fall 
prevention in patients with DM1. 
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SAMMANFATTNING PÅ SVENSKA 
Dystrofia myotonika typ 1 (DM1) är en neuromuskulär sjukdom som inte 
bara drabbar muskler utan flera organ i kroppen. Trots att DM1 är ovanlig är 
den ändå den vanligaste muskelsjukdomen bland vuxna, prevalensen är 3-
15/100000 invånare. 
Denna studie av muskelstyrka, balans, gångförmåga och antal fall inleddes 
då vi uppmärksammades på de ofta förekommande fallen hos patienter med 
DM1. En artikel från Skottland visade att antal fall var tiodubbelt högre hos 
dessa patienter än hos friska. Då våra patienter inte hade berättat om några 
fall började vi aktivt fråga efter dem, samt undersöka balansförmågan 
närmare. Vårt syfte med studierna var att, med reliabla balans- och gångtest, 
undersöka faktorer av betydelse för balansnedsättning och fallfrekvens, samt 
följa den naturliga utvecklingen av muskelstyrka och balans under fem år. 
Ett referensmaterial behövde också insamlas.  
Inget av de balanstest vi använde hade tidigare utvärderats för 
patientgruppen. Därför gjordes en studie av tillförlitlighet vid upprepad 
testning (test-retest) i balanstest under statiska (stillastående) och dynamiska 
(under rörelse) förhållanden samt gångtest (Studie I).  I den andra studien, 
som var en tvärsnittsstudie, deltog 51 patienter mellan 20 och 60 år. Vi mätte 
muskelkraft i benen, gång 10 meter, Timed Up&Go (TUG) och Step test 
(Studie II). Patienterna fyllde även i enkäter om balanstilltro, gångförmåga 
och fall. Ett referensmaterial inhämtades för gång 10 meter, TUG och Step 
test utifrån 220 undersökta personer.  I den prospektiva studien (Studie III) 
upprepades undersökningen efter tre och fem år. Fyrtiotre patienter deltog 
vid åtminstone två tillfällen och räknades in i analysen. 
Studie I visade att de dynamiska testen TUG, Step test och gångtest med 
maximal gånghastighet var mest tillförlitliga efter analys av både absolut 
variation och relativ reliabilitet.  
Studie II visade att det var vanligt med fall även bland våra patienter, samt 
att muskelstyrka och dynamisk balans var signifikant lägre än de 
referensvärden för friska individer som vi hade tillgång till respektive 
samlade in. Faktorer av betydelse för dynamisk balans var muskelkraft i de 
undersökta benmusklerna, totalt, samt de enskilda benmusklerna var för sig, 
där fotlyftarna (i 10 meters gång med maximal hastighet, samt Step test) och 
knäböjarna (i 10 meters gång med självvald hastighet, samt TUG) visade en 
något starkare korrelation än de mer bålnära musklerna. Faktorer av 
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ett starkt samband med fallfrekvens. Risken för frekventa fall ökar med 49% 
vid varje minskning med 10 poäng på den 100-gradiga skalan. 
Studie III visade att muskelstyrkan i samtliga undersökta muskler, hos 
patienterna med DM1, efter fem år minskade signifikant. Inom gruppen var 
det stor skillnad på balansfunktionen hos dem som bara var svaga distalt 
(fotledsmuskler) och dem som var svaga även i mer bålnära muskler (knä- 
och höftmuskler). Det var också efter fem år en ökande skillnad mellan män 
och kvinnor; männens kraft minskade signifikant i samtliga muskelgrupper, 
men hos kvinnorna endast kraften i höftböjarna. Den dynamiska balansen, 
mätt med TUG och Step test försämrades signifikant hos samtliga. Det 
gjorde också tilltron till balansen, mätt med ABC-skalan, där 40% av 
patienterna angav en minskad tilltro med 10 poäng eller mer. Männen hade 
en signifikant minskning av tilltron till balansen (medel och median -10.1 
punkter, p=0.04), men inte kvinnorna. Efter fem år hade andelen patienter 
som upplevt minst ett fall under senaste året ökat från 58% till 77%, och 
andelen patienter som behövt uppsöka någon form av vårdinrättning efter 
fall hade ökat från 16% till 42%. 
Att falla när man är muskelsvag kan innebära stora skaderisker, särskilt som 
förmågan att skydda sig minskar när armmusklerna också är svaga. Många 
patienter hade slagit i ansikte/nacke (en del flera gånger), och olika 
extremitetsfrakturer förekom. Det finns en risk att man upphör att vara 
fysiskt och socialt aktiv om man är rädd för att ramla och på fem år ökade 
andelen som undvek aktiviteter (på grund av rädsla för att falla) från 42% till 
60%. 
Dessa patienter behöver följas fortlöpande och bör få information, träning 
samt hjälpmedel. Målet är att patienten i största möjliga utsträckning skall 
kunna fortsätta vara aktiv utan att drabbas av fallolyckor med risk för 
skallskador eller arm-/benfrakturer. 
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6MWT 
10mCOM  
10mMAX 
Six-minute walk test 
10 meter walk in comfortable pace 
10 meter walk in maximum pace 
ABC 
BBS 
Chi2, χ2 
Activities-specific balance confidence  
Berg’s balance scale 
Chi squared  
CI95% Confidence interval of 95% 
CTG 
CUG 
Cytosine-Thymine-Guanine 
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DM1 Myotonic dystrophy type 1 
DMPK 
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Myotonic dystrophy protein kinase 
Falls Efficacy Scale 
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IQR 
MD 
Interquartile range 
Muscular dystrophy 
ME 
MIRS 
MMT 
Measurement error 
Muscular impairment rating scale 
Manual muscle test 
NMD 
OLS 
Neuromuscular disorders 
One leg stance 
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DEFINITIONS IN SHORT 
Centre of gravity  the vertical projection of the centre of mass 
(Shumway-Cook and Woollacott, 2007) 
Centre of mass  
 
the point that is at the centre of the total body 
mass, the variable believed to be controlled by the 
postural control system (Shumway-Cook and 
Woollacott, 2007)  
Dynamic balance  in this thesis defined as postural control in 
locomotion, in contrast to in still standing (static 
balance)  
Fall 
 
“an event, which results in a person coming to rest 
inadvertently on the ground or floor or other lower 
level and other than as a consequence of 
sustaining a violent blow, loss of consciousness, 
sudden onset of paralysis as in stroke or an 
epileptic seizure” (Kellogg, 1987) 
Functional balance the skill of maintaining postural control during 
locomotion, which is evaluated with performance-
based measures of functional balance, see 
”Dynamic balance” (Shumway-Cook and 
Woollacott, 2007)  
Muscle force the muscle influence that causes a body part to 
move or resist movement 
Muscle strength  the maximal amount of force exerted in a single 
attempt (Deschenes, 2004) 
Newton the unit for force. One newton is the amount of 
force needed to give the mass 1 kilogram an 
acceleration of 1 m/s2 
Postural control a complex motor skill derived from the interaction 
of multiple sensorimotor processes with the two 
main functional goals of postural orientation and 
postural equilibrium (Horak, 2006, Shumway-
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Cook and Woollacott, 2007) 
Static balance In this thesis defined as postural control in still 
standing, in contrast to in locomotion (dynamic 
balance) 
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1 INTRODUCTION 
For me as a physiotherapist the first encounter with patients who had 
myotonic dystrophy was unforgettable in many ways. It was not just the odd 
phenomenon of myotonia in the handshake and the gait pattern with typical 
slapping forefoot, together with a face marked by muscle wasting; there was 
something more. Their personality was odd, with dysexecutivity and 
difficulties in social interaction, typically aggravated by fatigue. These 
patients had difficulty trusting new caregivers as they had often been 
misunderstood, and had felt mistreated by and uncomfortable with the 
common welfare or primary care professionals knowing so little about this 
neuromuscular disorder. Some caregivers might have seen the patients as 
learning disabled, and had failed to see the complex symptomatology leading 
to a correct diagnosis of this hereditary disorder. Some patients denied their 
problems and defended their belief of normality by all means. At this time a 
Scottish study was published, showing that stumbles and falls increased 
tenfold in patients with myotonic dystrophy type 1 compared to healthy 
controls, with respect to activity level (Wiles et al., 2006). Not a single 
patient had spontaneously mentioned any frequent falls to us before. Thus, 
this was a starting point for our studies. After a while, they admitted not only 
that they had fallen but some also mentioned that, because of their stumbles 
or their slurred speech, they had not been allowed to visit the local pub or 
restaurant. Their participation in society at large was therefore limited. 
It is worth trying to enable the growth of confidence in patients; the 
rehabilitation team can really make a difference in these patients’ lives. This 
thesis focuses on the muscle force loss, the falls and fear of falls, and the 
postural control impairments most patients with DM1 will experience, and 
the physiotherapy aspects of these functional limitations. There is a lot more 
to discover. 
1.1 Neuromuscular disorders 
Weakness, in association with muscle atrophy and decreased muscle tone, is 
the main characteristic symptom of the neuromuscular disorders (NMD). 
This stands in contrast to neurological disorders primarily affecting the 
central nervous system, such as multiple sclerosis and stroke, where the 
paresis is associated with an increased muscle tone and less pronounced 
atrophy. The neuromuscular disorders may be acquired or inherited. The 
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inherited disorders can have different timing with respect to onset, i.e. at 
birth, during the first year or later in life.  
The prevalence of NMD’s among adults is approximately 1/1000 (Emery, 
1991, Ahlstrom et al., 1993). The NMD’s include more than 685 different 
diagnoses; each of them is rare (Kaplan and Hamroun, 2013). The origin of 
the inherited NMD’s is a genetic defect which in turn affects one part of the 
motor unit: the alpha motor neuron cell body in the anterior horn of the spinal 
cord; the peripheral nerve; the endplate; or the muscle fibre itself (Emery, 
1991, Kaplan and Hamroun, 2013). The motor neuron diseases, neuropathies 
and endplate disorders, as well as the acquired muscle disorders, are not the 
focus of this thesis. The inherited disorders of muscle encompass muscular 
dystrophies, myopathies and the myotonic disorders. The myotonic disorders 
are divided in the non-dystrophic disorders, i.e. myotonia congenita Thomsen 
or Becker and the dystrophic disorders, i.e. myotonic dystrophy type 1 
(Steinert, 1909) and 2 (Liquori et al., 2001). 
The impairments of patients with neuromuscular disorders are multiplex. 
Besides impairments related to muscle weakness in some disorders, patients 
frequently have affected cardiac function, either as conduction defect or heart 
failure (Bushby et al., 2003), in others the nervous system is affected giving 
cognitive impairments (D'Angelo and Bresolin, 2006). Impaired hearing or 
affected vision may be part of some NMD’s (DiMauro et al., 1998).  
The development of muscle function is complex. In healthy children the 
muscle force increases with age, as does the motor performance. In patients 
with muscular dystrophies there is a loss of muscle strength over time leading 
to impairment of locomotion, upper extremity function and hand grip. In 
some NMD’s loss of strength in bulbar muscles leads to impaired speech, 
chewing and swallowing (Sonies, 1997). Loss of strength in respiratory 
muscles may give hypoventilation and/or impaired cough (Wallgren-
Pettersson et al., 2004). Loss of strength in core muscles may lead to 
scoliosis, which sometimes demands surgical intervention (Mullender et al., 
2008). A pronounced weakness in the extremities could lead to joint 
contractures (Vignos, 1983). Muscle pain is related to overuse or disuse of 
weak muscles in patients with NMD’s (Bushby et al., 1998, Abresch et al., 
2002). 
1.2 Myotonic dystrophy type 1 
The most common inherited myopathy among adults is myotonic dystrophy 
type 1 (DM1; Steinert’s disease) (Steinert, 1909). The prevalence in Europe 
8
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is approximately 3-15/100 000 (Harper, 2001), but it differs greatly from 
region to region in the world. It has a high prevalence (189/100 000) in the 
northeast region of the Quebec province, Canada (Mathieu et al., 1990) and 
is as rare as 0.9/100 000 inhabitants in Taiwan (Emery, 1991). At the 
Neuromuscular Centre in Gothenburg, the reference centre for 
neuromuscular disorders in the Western part of Sweden, the number of 
known diagnosed adult patients (≥18 years) with DM1 was 110 in 2006. The 
number of adult inhabitants in this part of Sweden was 910 000 this year, 
which makes the prevalence in the adult population 12/100 000. This lies in 
the upper part of the European range. In an epidemiologic study in Örebro 
county 1993, Ahlström found 19 patients with myotonic disorders per 100 
000 inhabitants (Ahlstrom et al., 1993). 
The gene defect in DM1 is an unstable expansion of CTG trinucleotide 
repeats in a non-coding region of the myotonic dystrophy protein kinase 
(DMPK) gene on chromosome 19 (Brook et al., 1992, Fu et al., 1992). 
Individuals in the general population have less than 35 CTG repeats. A repeat 
length between 35 and 49 is considered a premutation. A length of 50 CTG 
triplets or more is pathogenic. There is a rough positive correlation between 
number of repeats and the severity of the disorder (Salehi et al., 2007) and a 
negative correlation with age of onset. Patients with the congenital form of 
DM1 usually have 1000 up to >2000 repeats. 
DM1 has an autosomal dominant inheritance, and affects males and females 
equally. There is a considerable risk of anticipation, i.e. the CTG expansion 
increases when transmitted to the next generation. This is particularly evident 
when the mother is the mutation carrier. The child will thus have an 
markedly increased CTG expansion and a more severe form of DM1 
compared to the affected parent (Howeler et al., 1989).  
DM1 is a RNA-mediated disease, where the RNA with CUG repeat 
expansions accumulates in nuclei and impairs splicing of several different 
genes. This explains why the expanded CTG-repeats in a non-coding region 
of the DMPK gene can do so much harm in different body structures (Ranum 
and Cooper, 2006). 
The DM1 is a multi-system disorder. Functional disturbances in different 
organs - the heart, eyes, stomach and brain - are common (Gagnon et al., 
2007a, Gagnon et al., 2007b). The organs and tissues most affected in DM1 
are those that consist of non-renewing cells, such as the skeletal muscle, the 
heart and the central nervous system (Melacini et al., 1988, Minnerop et al., 
2011) The respiratory system can also be affected, with hypoventilation with 
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hypercapnea due to weakness of respiratory muscles, while some patients 
have central and obstructive sleep apnoea (Begin et al., 1983, Yu et al., 2011, 
Pincherle et al., 2012). Dysphagia is a life-threatening symptom, often 
evolving later in life (LaDonna et al., 2010). The expected life span of 
patients with adult-onset DM1 may be shortened, median survival was shown 
to be 60 years for males and 59 for females (de Die-Smulders et al., 1998). 
The most frequent primary causes of death, in this register study on 180 
adult-onset patients, were pneumonia and cardiac arrhythmias. The definition 
of adult-onset was age at onset between 10 to 50 years of age, myotonia and 
progressive weakness, and absence of mental retardation (de Die-Smulders et 
al., 1998). 
The characteristic symptoms, though, are muscle wasting and progressive 
muscular weakness, typically first noticed in the distal muscles of upper and 
lower extremities. There is also the myotonic phenomenon, a delayed muscle 
relaxation, which is due to a reduced chloride conductance (Logigian et al., 
2005). The muscular weakness is a progressively disturbing obvious 
symptom. The myotonic feature can also be disabling, but usually diminishes 
as the weakness increases. Histopathological findings are marked type I 
muscle fibre atrophy and central nuclei (Vihola et al., 2003, Angelini and 
Tasca, 2012). When the genetic mutation was discovered the use of muscle 
biopsy for diagnosis was terminated and now a blood sample is sufficient to 
determine a DM1 diagnosis. 
At present, there is no cure for patients with inherited neuromuscular diseases 
including DM1, but the research on gene therapy or protein restitution 
therapy is on-going. Medical interventions though, have increased life span 
and improved the quality of life of many patients with NMD’s. These 
interventions can include cardiac and respiratory care, alleviative medication 
and nutritional support. From the rehabilitation point of view there are 
different kinds of physical and occupational therapy interventions, including 
hand exercise programmes (Aldehag et al., 2013) and assistive equipment, as 
well as individualised exercise programmes focusing on e.g. breathing and 
coughing techniques (Yeldan et al., 2008); strength (Lindeman et al., 1995, 
Tollback et al., 1999, Nilsagård and Kånåhols, 2004, Sjogreen et al., 2010); 
aerobic/physical exercise (Ørngreen et al., 2005, Kierkegaard et al., 2011a); 
or multidisciplinary rehabilitation programmes (Missaoui et al., 2010). 
The patient 
The DM1 disorder is classified in relation to the symptom debut as: 
congenital (0-1 year); childhood (1-10 years); classical/adult (>10 years or 
early adult); and late onset/mild form (>40 years) (Harper, 2001). A majority 
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of the individuals with congenital DM1 have a learning disability (Ekström et 
al., 2009). 
The patients in our study had childhood, classical or mild form DM1. The 
patient with the childhood form often has experienced school difficulties, 
abdominal problems, clumsiness and indistinct speech (Harper, 2001, Meola 
and Sansone, 2007). The extremity muscle symptoms are usually not 
prominent until adolescence or early adulthood. Cardiac conduction 
abnormalities may be found from 10 years of age (Bassez et al., 2004). The 
patient with the classical/adult form presents with the typical muscle 
symptoms myotonia and progressive muscle weakness in adolescence or 
early adult life. These symptoms start in the distal and facial muscles. The 
patients may also have excessive daytime sleepiness, irritable bowel 
syndrome and cardiac rhythm abnormalities (Harper, 2001, Angelini and 
Tasca, 2012, Laberge et al., 2013). The personality trait may be pathologic, 
with mostly dependant or harm avoidant personality (Winblad et al., 2005). 
The patient with the late onset/mild form could present with cataracts in 
middle age. Muscular symptoms are rare and mild. They are recognised as 
patients with DM1 in the mapping of relatives with the disorder in order to 
prevent cardiac arrests. 
Another way to classify patients with this disorder is according to the 
severity of muscular impairment. This classification is named the muscular 
impairment rating scale, MIRS, elaborated by Mathieu et al (Mathieu et al., 
2001). Manual muscle testing of 11 muscle groups bilaterally is the base of 
the MIRS grading system (see Methods, 3.3 Procedure - Classification for 
more details).  
In the skeletal muscle of a patient with DM1 there is an on-going disease 
process (Ono et al., 1986). Usually the strength decrease starts in the 
patient’s oral or facial muscles bringing about nasal speech and a myopathic 
face (facies myopathica) (Mathieu et al., 2001, Sjögreen et al., 2007). The 
myotonia phenomenon is prominent in the early stages of the muscle strength 
decrease, and shows primarily in the handgrip and the tongue. As the 
dystrophy proceeds, the patient’s handgrip, wrist extensors, neck flexors and 
ankle dorsiflexors decrease in strength (Harper, 2001, Mathieu et al., 2003). 
As the muscle strength decreases it will, secondarily, affect the patient’s gait 
pattern and postural control. At the early stage the patient’s impairments 
could be negligible, but when the muscle strength in the feet and shanks 
weakens further, the patient starts to walk with a foot tap, stumble and 
eventually, fall (Horlings et al., 2009). 
11
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Most of the patients with non-congenital DM1 are ambulant until their 6th 
decade. Gait velocity, walking distance, walking aids, and stair walking 
could be important parameters for assessing activity and participation in 
general life. Progression of muscle weakness is expected (Johnson et al., 
1995, Harper et al., 2002, Contardi et al., 2012). Ergonomic interventions as 
well as physical advice are increasingly important, as many adults with DM1 
have a low physical activity level (Lindwall, 2010, Kierkegaard et al., 
2011b). Secondary to the muscle weakness, the patient may also complain of 
an impaired balance resulting in stumbles and falls, often in conjunction with 
walking (Wiles et al., 2006).  
There is a high variability in function and physical impairment between 
patients with DM1, as well as in cognitive function (Winblad et al., 2006, 
Gagnon et al., 2008). A common problem in this patient group is the gastro-
intestinal dysfunction, with e.g. stomach pain and diarrhoea (Harper, 2001). 
As the DM1 disease is dominantly inherited, patients with DM1 may have 
children at home with similar or worse impairment (Gagnon et al., 2007b). 
Their children may be severely learning disabled and/or have an autism 
spectrum disorder (Ekström et al., 2008). These everyday bodily infirmities, 
cognitive problems and social situations may also lead to frequent 
cancellations and loss to follow-up medical appointments or research studies 
(Tollback et al., 1999, Ørngreen et al., 2005, Gagnon et al., 2007a). Hence, it 
is important to customise any planned intervention in this patient group. 
1.3 Description and evaluation of affected 
areas of body function 
1.3.1 Muscle function 
Some aspects of muscle function are power, strength and endurance 
(Deschenes, 2004). Power is defined as “explosive strength”; strength is “the 
maximal amount of force exerted in a single attempt”, and muscular 
endurance is “the capacity to resist muscular fatigue, particularly when the 
resistance is submaximal” (Deschenes, 2004). In this thesis the only muscle 
function parameter assessed is muscle strength, defined as the maximal 
amount of isometric muscle force exerted in a single attempt. Muscle force 
causes a body part to move or resist movement; force is measured in newton, 
N. 
In healthy individuals muscle strength reaches its peak at about 30 years of 
age. The more prominent decline normally starts between 50 to 60 years of 
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age, and there is a more rapid course beyond the age of 60 years (Larsson et 
al., 1979, Deschenes, 2004). Both men and women exhibit the same rate of 
muscle strength decrease (Lindle et al., 1997). In healthy adults, during 
ageing, the skeletal musculature undergoes sarcopenia, the degenerative loss 
of muscle mass (uppermost the fast type II-fibres), muscle strength and 
muscle function (Thompson, 2009, Cruz-Jentoft et al., 2010). The rate of 
sarcopenia in humans older than 50 years is estimated to 1-2% per year 
(Thompson, 2009). Unlike the histopathologic findings in DM1 patients, the 
age-related loss occurs preferably in the type II fibres. Later, in senescence, 
an age-associated hypotrophy is also seen in the type I fibres (Thompson and 
Brown, 1999). 
Evaluation of muscle strength 
Common ways to clinically quantify muscle strength are: 1) rough estimation 
of isometric and dynamic muscle strength against manual resistance; 2) 
functional muscle strength tests, e.g. counted heel-raisings or knee-bowings; 
3) manual muscle testing with Medical Research Council scale (MRC, 1978) 
with positions according to Janda (Janda, 1983); 4) quantitative handheld 
isometric measurements, with a force gauge dynamometer; and 5) 
quantitative dynamic muscle strength measurements with e.g. 
isokinetic/isotonic apparatus. 
Rough muscle strength tests and functional muscle strength tests assesses 
side differences and strength reduction related to the examiners experience 
and judgment of “normal” strength.  
The manual muscle testing is a widely used assessment tool with explicit 
measurement starting positions and measures strength throughout the range 
of motion. It aims at giving information on dynamic muscle strength, but is 
found to be not sensitive enough to be useful in most research studies, even 
after modifying to more scale steps (Florence et al., 1992, Bohannon, 2005, 
Gagnon et al., 2013). Nevertheless, it was used in a study of physical profile 
in patients with DM 1 (Nitz et al., 1999) and in the classification of muscular 
impairment of patients with DM1, MIRS (Mathieu et al., 2001). 
Handheld dynamometry is considered one of the most reliable measurements 
of isometric muscle force possible to use in the clinical setting. When 
quantifying moderate muscle strength impairments in DM1 handheld 
dynamometry has shown advantages over manual muscle testing, and has 
been recommended for use in patients with neuromuscular disorders (Escolar 
et al., 2001, Hebert et al., 2010). Reference values of muscle force in newton 
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are available for both upper and lower extremities (Bäckman et al., 1995, 
Phillips et al., 2000). 
One limitation of all manual muscle testing methods, including handheld 
dynamometry, is the examiner’s own strength and subsequent difficulties 
with stabilisation, which can occur when testing strong muscles. In some 
muscle groups “normal” muscle strength could be difficult or impossible to 
measure with a handheld dynamometer (Bohannon, 1988). In patients with a 
progressive muscle weakness due to a neuromuscular disorder this is seldom 
a problem. However, in strong muscles, e.g. in male patients with the mild 
form of DM1, this has to be taken into account.  
The strength measurement method using a handheld dynamometer can be 
applied either with the “make” or the “break” method (Bohannon, 1988). In 
both methods the isometric muscle force is generated during 3-4 seconds in a 
well-described position against a resistance (the dynamometer) at a well-
described anatomic landmark. The positions are in most cases neutral to 
gravity. The difference is the way to end the measurement, holding 
completely still in the “make” method; or the patients’ maximal force effort 
is overcome by the examiner and the joint gives way, the “break” method 
(Bäckman et al., 1995, Phillips et al., 2000).  
Dynamic muscle strength measurement with computerised isokinetic/isotonic 
apparatus was not used in this thesis, but it is unlikely that test reliability 
would have increased in a way that would have changed the possibilities to 
draw any further conclusions (Bäckman, 1988).  
1.3.2 Gait 
The ability to walk is a prerequisite for a number of activities and also 
sometimes for active participation in society, since it gives the able bodied 
person a greater freedom of choice (Kierkegaard and Tollbäck, 2007). 
Walking is also recognized as one of the best forms of physical activity for 
older adults, and great benefits can be gained through regular walking 
(Morris and Hardman, 1997). Muscle weakness affects the gait through 
decreasing speed (Busse et al., 2006), changing the gait pattern (D’Angelo et 
al., 2009, Galli et al., 2012) and increasing the risk of stumbles and falls 
(Wiles et al., 2006). The gait pattern in patients with DM1 often shows a 
“foot tap” early as the ankle dorsiflexors (m. tibialis anterior and mm. 
peronei) weaken, but when the disorder progresses other gait alterations may 
appear, e.g. hyperextension of the knees if the m. quadriceps wastes away 
and a shorter step length if the plantar flexors (m. triceps surae) becomes 
14
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weak (Fish and Nielsen, 1993). This could all affect the activity level of the 
patient with the neuromuscular disease DM1 (McDonald, 2002). 
Evaluation of gait 
Gait can be assessed qualitatively, to evaluate disorder-typical tripping, 
ataxia or spastic gait patterns; or quantitatively, as speed in meter/second, or 
the time to walk a specified distance, e.g. 10 or 30 meters (Wade, 1992). 
Other quantitative gait variables are stride length, step frequency, and 
cadence. The time to walk a flight of stairs could also be included in the 
assessment of gait (Wade, 1992). The six-minute walk test has been used in 
patients with DM1 to evaluate walking capacity and exercise tolerance 
(Kierkegaard et al., 2011a). Subjectively the patient could estimate the 
maximum walking distance possible. 
Measurements of gait can be performed in many ways, with different kinds 
of technical equipment. There are “Gait mats” (GaitMat™, GAITRite® etc.), 
video-analysis and laboratory measures that are examples of technically 
advanced and expensive tests. Gait speed measurement assumes a constant 
movement, without acceleration (or deceleration). As we wanted to include 
the sometimes slow start of the DM1 patients, we chose to measure time to 
walk 10 meters (Wade, 1992, Robertson et al., 2006, Graham et al., 2008). 
Reference values of time to walk 10 meters, in healthy men and women 
between 20 to 59 years of age, had to our knowledge previously not been 
published although walking speed (without acceleration and deceleration 
phases) is thoroughly evaluated (Öberg et al., 1993, Al-Obaidi et al., 2003, 
Bohannon, 2008). Missaoui et al. have published a study reporting results of 
a rehabilitation programme with a retrospective analysis, including gait speed 
in spontaneous and fast condition (Missaoui et al., 2010), but a prospective 
study of the gait performance in patients with DM1 has not previously been 
published. 
1.3.3 Postural control 
The function of maintaining postural stability and equilibrium of the body 
during static and dynamic conditions is complex. In this thesis the theoretical 
background to postural control, as it is explained in physiotherapy research, 
is adopted (Horak, 2006, Shumway-Cook and Woollacott, 2007). A dynamic 
integration of the sensory (visual, somatosensory and vestibular), 
musculoskeletal, nervous and cognitive systems is required for postural 
control. Extrinsic factors as the environment and the task itself, as well as 
intrinsic factors as personality and biomechanical restraints, influence the 
resulting performance of the movement tasks (Shumway-Cook and 
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Woollacott, 2007). The concept of balance is used as a synonym to postural 
stability which means “the ability to control the centre of mass in relationship 
to the base of support” (Shumway-Cook and Woollacott, 2007), p.158. Tests 
that examine the ability to perform functional tasks requiring postural 
control, in locomotion, are in this thesis named “dynamic balance tests”. 
Tasks reflecting steady-state postural control are called “static balance tests”.  
Static condition 
Postural orientation and postural stability are the functional goals of postural 
control (Shumway-Cook and Woollacott, 2007) p.160. The base of support is 
crucial in static conditions. Lost postural stability in steady-state demands 
different strategies to be recovered. They can be named “fixed base of 
support strategy” vs. “changing base of support strategy”. Sometimes they 
are simply named ankle, hip or step strategies (Nashner, 1987, Shumway-
Cook and Woollacott, 2007) pp.165-169. Normally which muscles activate to 
maintain equilibrium is a continuum of movements. The use of the fixed base 
strategy with help from the ankle requires an intact range of motion and a 
certain amount of muscle strength in the postural muscles of the lower leg, 
m. soleus, m. gastrocnemius and m. tibialis anterior (Horak, 2006). The 
individual will as a reflex use this strategy to cope with small perturbations 
on firm ground. Being unable to counteract the disruptive movement with the 
lower leg muscles a rapid movement in the hip region (flexion/extension) 
will be performed. When the fixed base strategy is insufficient the individual 
will take a step to regain equilibrium, i.e. use the changing base of support 
strategy (Nashner, 1987, Horak, 2006, Maki et al., 2008).  
Dynamic condition in standing 
In dynamic conditions postural adjustments are used in a proactive way, a 
stabilising of the body precedes a voluntary movement. Anticipatory and 
feedback control mechanisms are used to adjust forces needed for postural 
stability (Shumway-Cook and Woollacott, 2007).  
Postural control in locomotion 
The concept of locomotion requires progression, postural control and 
adaptation ability. The movement pattern has to be flexible to meet expected 
and unexpected obstacles, and allow a change of speed if needed. The step 
length will be reduced when walking on e.g. slippery or icy surfaces (Patla, 
1997). The demands on postural control increase when stepping over 
obstacles (Chou and Draganich, 1997, Hahn and Chou, 2004). Attention 
processing resources are required in locomotion, the quantity depending on 
the difficulty of the task (Chen et al., 1993, Maki and McIlroy, 2007). 
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Dynamic balance tests reflect in part the functional balance skills; e.g. the 
postural control and adaptation ability in every-day movements.  
Many falls occur when turning around. The turning strategies have been 
studied in healthy, young individuals (Hase and Stein, 1999). The spin-turn 
and the step-turn strategies were shown. While the latter is stable and easy, 
having a broad base of support, the spin-turn is the more unstable method.  
Evaluation of postural control 
As postural control depends on the function in several contributing systems, 
the test of postural control has to reflect this. The clinical assessments of 
balance should include tests of several different aspects of postural control 
(Pollock et al., 2000, Horak, 2006). The assessment should be selected from 
knowledge and understanding of balance and postural control, and be 
associated with what the specific individual performs. The different 
impairments of postural control have induced a development of various 
assessment tools to assess balance: e.g. the Berg Balance scale (BBS) (Berg, 
1989), Functional Reach Test (FRT) (Duncan et al., 1990), Timed Up & Go 
(TUG) (Podsiadlo and Richardson, 1991), Activities-specific Balance 
Confidence scale (ABC) (Powell and Myers, 1995), Step test (Hill et al., 
1996) and the Balance Evaluation Systems Test (BESTest) (Horak et al., 
2009).  
The most common still-standing balance tests are: standing on one leg; 
Romberg’s test (feet together, closed eyes) and sharpened Romberg (tandem 
stance) (Briggs et al., 1989). Open or closed eyes, firm or soft ground, 
horizontal or tilted surface can vary the postural control demands. Some of 
these tests are often included in the more complex balance measurement 
scales (Berg, 1989, Horak et al., 2009). The BBS, TUG and FRT has been 
used in patients with DM1 (Missaoui et al., 2010). 
The performance-based measure of functional balance skills, Timed Up & 
Go test (Podsiadlo and Richardson, 1991), was developed by Podsiadlo from 
another measure, “Get Up & Go”, in which the quality and fall risk were 
assessed (Mathias et al., 1986); TUG also included timekeeping. TUG was 
primarily aimed to assess basic mobility skills in frail elderly persons, but has 
been further applied in e.g. stroke and vertigo patients and modified for use 
in children (Whitney et al., 2004, Ng and Hui-Chan, 2005, Williams et al., 
2005). TUG has demonstrated ability to distinguish fallers from non-fallers 
in older people, cut-off has been set to >14 seconds (Andersson et al., 2008). 
Construct validity was demonstrated as TUG could discriminate between 
subjects’ dependence. All completing TUG in < 20 seconds were 
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independent in basic transfers. Subjects requiring ≥ 30 seconds were 
dependent (Podsiadlo and Richardson, 1991). The use of TUG in patients 
with DM1 has previously not been evaluated for test-retest reliability, and 
reference values for healthy men 20-59 years of age are not previously 
established (Bohannon, 2006). 
In the Step test by Hill (Hill et al., 1996) the patient does not climb the 
platform, just place the foot on it and then take it down again, repeatedly, as 
fast as possible. It aims to assess the ability to maintain balance while 
performing a fast dynamic single limb stepping task. The original study 
evaluated the test in relation to two platform heights, 7.5 and 15 cm. The 
lower height was recommended. Normal values for women 20-80 years of 
age have been published for the 7.5 cm height (Isles et al., 2004). The test 
has not previously been evaluated for use in patients with DM1, and further 
the test lacked reference data for men. 
1.3.4 Perceived balance confidence and walking 
ability 
The subjective perception of balance confidence and walking ability are 
important tools to understand and become aware of the difficulties the 
patients are experiencing. “Perceived self-efficacy is concerned with 
judgments of how well one can execute courses of action required to deal 
with prospective situations” (Bandura, 1982). A high sense of self-efficacy 
may enhance effective solutions to upcoming postural instability, as well as 
individuals with a low sense of efficacy may more easily visualize failures 
and potential falls (Bandura, 1989). Instruments assessing self-efficacy in 
walking and balance are often used in studies on older people, as falls and 
decreased balance are more common, and more hazardous, in the elderly. As 
no earlier studies of perceived balance in patients with DM1 had been 
performed, we tried to find some well-described, simple and 
psychometrically analysed questionnaires, with relevant items or activities 
for the patient with DM1.  
Patient reported outcome measures 
Two well-renowned questionnaires were the Falls Efficacy Scale (FES) 
(Tinetti et al., 1990), later modified and translated to the Swedish version, 
FES(S) (Hellström and Lindmark, 1999); and the Activities-specific Balance 
Confidence scale (ABC) (Powell and Myers, 1995). Both are developed to 
study older populations. The FES has been shown to correlate with walking 
pace, anxiety and depression in the elderly (Tinetti et al., 1990), and both 
FES and ABC could discriminate between high and low mobility individuals 
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as defined by perceived need for personal assistance to ambulate outdoors 
(Powell and Myers, 1995). The FES was more appropriate for assessing 
balance confidence in more frail seniors. The ABC scale, though, was more 
adequate to use in more highly functioning (elderly) individuals or 
individuals at various levels of function, and could more clearly separate the 
two mobility groups. Both questionnaires have the ability to reflect clinically 
meaningful changes over time, if used in the proper group (Powell and 
Myers, 1995).  
The self-reported walking index (RW-index) was developed to measure the 
subjective opinion on current walking difficulty (Bergland et al., 2002, 
Bergland et al., 2006). The RW-index has its origin in Scandinavia, which 
could support its feasibility of use in a Swedish population.  
1.4 Falls 
A fall is defined by WHO as “an event, which results in a person coming to 
rest inadvertently on the ground or floor or other lower level” (Kellogg, 
1987, WHO, 2012). This definition is also used in this thesis. For greater 
clarity, only falls from standing or walking were asked to be reported. 
In October 2012 the World Health Organization’s Media centre published a 
fact sheet on falls claiming that falls “are the second leading cause of 
accidental or unintentional injury deaths world wide”. To prevent falls the 
WHO advises fall-related research and establishing effective policies to 
reduce risk, together with education, training and creating safer environment 
(WHO, 2012). 
The aims of fall prevention programmes are, according to WHO: reduction of 
“the number of people who fall; the rate of falls, and the severity of injury 
should a fall occur”. Further, the WHO is very clear in the description of fall 
prevention programmes for older individuals, a small section of the advice 
follows: “muscle strengthening and balance retraining prescribed by a trained 
health professional; prescription of appropriate assistive devices to address 
physical and sensory impairments; community-based group programmes 
which may incorporate fall prevention education and Tai Chi-type exercises 
or dynamic balance and strength training…” 
Tripping and slipping 
Research on falls has shown that most falls among older people result from 
tripping over an object (35-47%) and slipping (27-32%) (Overstall et al., 
1977, Gabell and Simons, 1985). Inadequate slip recovery was in a study 
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shown to depend on a lower rate of muscle activation in the support limb 
(Tang and Woollacott, 1998). Determinants for recovery from trips have 
been studied (Shumway-Cook and Woollacott, 2007). It was shown that the 
hip flexors of the swing leg and the ankle plantar flexors of the stance leg 
were the most critical muscles for recovery (Chen et al., 1993). Furthermore, 
the study showed that an even more critical factor than muscle strength 
appeared to be how fast the restorative forces could be generated. Following 
experimental induced trips in a lab on a healthy experimental group with 79 
participants, age mean (SD) 72.5(5) years, women fell four times more often 
than men and the younger among the women (65-70 years of age) fell more 
often than the older (Pavol et al., 1999). The age of the men did not affect the 
trip outcome, only one man fell, he was >75 years old. The majority of the 
induced trips did not result in a fall. 
Activity restriction associated with fear of falling has shown to be an 
independent predictor of decline in physical function, in an elderly 
population (Deshpande et al., 2008). 
To follow the WHO intentions, a primary goal is to find out which older 
individuals are falling, and if it is possible to make assumptions about risk of 
falling. According to WHO, the fall-related mortality rates (per 100000 
population) have the highest numbers in the European region; and in all 
regions of the world, adults over 70 years (particularly females) have 
significantly higher fall-related mortality rates than younger people.  
Evaluation of number of falls 
It is important to have a clear and simple definition of a fall, reliably 
understood by lay people, to be able to measure number of falls in 
individuals living at home. The prospective measurement of falls is the 
preferable method, and is practised in randomised controlled studies using 
diaries, calendars or postcards. Daily recording is recommended, and 
ascertainment details about the falls at least monthly (Hauer et al., 2006). A 
non-published pilot intervention study (at the Neuromuscular Centre in 
Gothenburg) discovered low compliance while using diaries in patients with 
DM1 even for a shorter time. 
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2 AIMS 
The overall purpose of this thesis was, in adult patients with DM1, to 
investigate factors of importance for functional balance skills and falls, and 
to investigate the natural course of muscle force and functional balance 
impairments, with reliable measurement methods. In addition, a purpose was 
to establish reference values in healthy men and women, 20-59 years old for 
timed 10-meter walk, Step test and Timed Up & Go.  
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3 METHODS 
3.1 Design 
All studies are quantitative studies with continuous and categorical data. 
Study I is a test-retest reliability study of static and dynamic balance tests 
including timed 10-m walk. 
Study II is a cross-sectional study of functional balance skills, timed 10-m 
walk, muscle force and self-reported balance confidence, walking ability and 
falls. Reference data of dynamic balance tests and timed 10-m walk is 
included. 
Study III is a prospective study over five years, with assessments at three 
occasions of functional balance skills, timed 10-m walk, muscle force and 
self-reported balance confidence, walking ability and falls. 
3.2 Subjects 
3.2.1 Patients with DM1  
When the studies began the number of genetically proven patients with DM1, 
living in the western part of Sweden, known and cared for at the 
Neuromuscular Centre at Sahlgrenska University Hospital in Gothenburg, 
were 110. Inclusion criteria were age between 20 and 60 years and ability to 
perform Timed Up & Go. Exclusion criteria were: other disorder interfering 
with postural control or the congenital form of DM1. Of these 110 were 38 
not invited, details on reasons for not being included is shown in Table 1. A 
dropout analysis of the remaining 72 individuals that were invited is shown 
in Table 2. 
3.2.2 Reference group 
In order to establish reference values for dynamic balance tests a healthy 
reference group was recruited by announcements in different work places; 
chemical factory, geriatric care, hospital, school and university. The 
individuals had to assert an absence of balance problems. The goal was to 
include 20 subjects of each gender and each age-decade between 20-59 years. 
The tests included walking 10 meters at a comfortable and maximum speed, 
TUG, and the Step test. 
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Table 1. Exclusion analysis of patients not invited, number and percent. 
N=38. 
 Excluded by: 
Rationale Age a  Congenital 
DM1 b 
Mobility 
impairmentc 
Other reasons d 
N (%) 
 
20 (53%) 
6/14 
9 (24%) 7 (18%) 2 (5%) 
a Bottom row n= <20 years / >60 years.  
b Congenital form due to medical card, or living in a community centre for cognitive impaired.  
c Mobility impairment due to medical card. 
d E.g. communication problem due to other native language. 
 
Table 2. Dropout analysis, number (%). 
Invited, N=72  Dropout 
Accepted Declineda No answer  Accepted, but 
dropped out 
54 (75%) 14 (19%)  4 (6%)  3 (6%) 
a Transport reasons, “too far to travel”, n=8. 
3.3 Procedure 
All 72 eligible patients with DM1 were invited by letter and/or by phone call 
to participate in the studies. Those who agreed to participate (n=51) were 
examined and made self-assessments at a single visit at the clinic, the cross-
sectional study (paper II). Those who agreed to return twice during the 
following weeks were included in the reliability study and were thus 
examined at three occasions (paper I). All patients who had participated in 
the cross-sectional study were invited to the same assessments in the 
prospective study (paper III), at three and five years after the first visit, 
Figure 1. The patients were asked to inform the investigator if they were 
aware of any contributors to postural control impairment other than muscle  
23
Elisabet Hammarén 
 
Table 1. Exclusion analysis of patients not invited, number and percent. 
N=38. 
 Excluded by: 
Rationale Age a  Congenital 
DM1 b 
Mobility 
impairmentc 
Other reasons d 
N (%) 
 
20 (53%) 
6/14 
9 (24%) 7 (18%) 2 (5%) 
a Bottom row n= <20 years / >60 years.  
b Congenital form due to medical card, or living in a community centre for cognitive impaired.  
c Mobility impairment due to medical card. 
d E.g. communication problem due to other native language. 
 
Table 2. Dropout analysis, number (%). 
Invited, N=72  Dropout 
Accepted Declineda No answer  Accepted, but 
dropped out 
54 (75%) 14 (19%)  4 (6%)  3 (6%) 
a Transport reasons, “too far to travel”, n=8. 
3.3 Procedure 
All 72 eligible patients with DM1 were invited by letter and/or by phone call 
to participate in the studies. Those who agreed to participate (n=51) were 
examined and made self-assessments at a single visit at the clinic, the cross-
sectional study (paper II). Those who agreed to return twice during the 
following weeks were included in the reliability study and were thus 
examined at three occasions (paper I). All patients who had participated in 
the cross-sectional study were invited to the same assessments in the 
prospective study (paper III), at three and five years after the first visit, 
Figure 1. The patients were asked to inform the investigator if they were 
aware of any contributors to postural control impairment other than muscle  
23
Force, falls and fear of falls in myotonic dystrophy type 1 
24 
Figure 1. Flowchart of the studies 
 
 
  
Study III:  n=43  
Included: n=46 
Dropout: n=3 (moved (1); DM1-
related (2))  
 
Dropout to assessment at 5-year follow-
up: n=2 (progress of DM1) 
 
220 healthy individuals 
volunteered in the 
reference data collection 
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n=10 
Accepted: n=11 
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38 patients were excluded from 
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Other, n=2 
 
Of the 72 invited, 14 patients 
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Table 3. Subgroup analysis of 4 individuals, excluded from the prospective 
study. Data from baseline / follow-up assessment at three or five year. 
 Excluded patients 
 ID 1 ID 2 ID 3 ID 4 
Follow-up 
occasion 
Five year Three 
year 
Five year Three year, at a 
home visita 
Years of age/sex 20/female 27/male 53/female 55/female 
MIRS, grade 2/2 1/1 1/1 5/5 
RWI, grade  12/12 12/12 12/12 6/6 
TUG, (seconds)  7.7/7.8 9.5/7.7 8.1/7.7 31.0/56.9 
DEX, (newton)  223/270 382/380 277/275 23.2/0 
Abbreviations: MIRS, muscular impairment rating scale; RWI, reported walking index; TUG, 
Timed Up&Go; DEX, Ankle dorsiflexion. 
aWheelchair user outdoors at three year. Deceased after four years, DM1 related. 
 
weakness. The prospective study (paper III) was performed with the same 
patients as the cross-sectional study, the exclusion criteria were the same, but 
the inclusion criteria for the analysis were narrower. All patients were 
followed, but for the analysis the patients needed to have muscular 
impairment symptoms corresponding to MIRS 3, 4 or 5 (see below, 
Classification) and be able to perform TUG in less than 30 seconds at their 
first visit. The reason for the former criterion was that patients with MIRS 1 
and 2 have the mild form of DM1, and thus have very little muscle 
symptoms. The mild form of DM1 is also reasonably stable over time, in our 
experience. The reason for the TUG criterion was that this cut-off in the 
elderly distinguishes between individuals dependent or independent in basic 
transfers; and that patients walking so slowly would in a three years 
perspective be likely to be a wheelchair user, and need other forms of care 
and support.  
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A subgroup analysis shows the characteristics of the excluded patients, Table 
3. One patient with slow TUG-time was deceased before the three-year 
follow-up and is therefore not described in this table. 
Classification 
MIRS is an ordinal five-point scale developed to assess the progression of the 
muscular involvement in DM1. Manual muscle testing of 11 muscle groups 
bilaterally is the base of the MIRS grading system. Patients are thus graded 
as follows: 1 - no noticeable muscular impairment; 2 - minimal signs, e.g. 
myotonia, facial weakness and nasality, but no distal weakness except 
isolated digit flexor weakness; 3 - distal weakness, no proximal weakness 
except in elbow extensors; 4 - mild to moderate proximal weakness; and 5 - 
severe proximal weakness, with movement restrictions due to gravity 
(Mathieu et al., 2001). 
Examiners 
One experienced physiotherapist assessed all patients with DM1 on all 
occasions, blinded to previous results. The questionnaires were always filled-
in during the first part of the visit in order for the patient not to be affected of 
the balance tests’ results. Resting pauses between the tests were allowed and 
encouraged. 
Three different examiners, one experienced physiotherapist and two 
physiotherapy students examined the reference group participants. The 
measurement methods were thoroughly practiced by the examiners to 
minimize measurement error.  
3.4 Measurements and assessments 
3.4.1 Muscle force  
In study II and III the isometric muscle force was measured, in newton, with 
a handheld gauge meter (Mecmesin Basic Force Gauge 1000 N, Chauvin 
Arnaux Group). The measurements were performed in the specific positions 
outlined by the reference guidelines (Bäckman et al., 1995, Phillips et al., 
2000). The knee extensor was assessed in sitting, with 90-degree flexion in 
the hip and knee; the examiner stabilised herself against a wall. The supine 
position was used in the hip flexor measurement, the hip in 90-degree 
flexion, with the knee flexed; and in the ankle dorsiflexor measurement with 
the distal leg supported on a small wedge pad. The prone position with 90-
degree knee flexion was used for the knee flexors. Each muscle was 
measured three times; the mean of the two highest results was recorded. The 
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resistance was gradually increased in the gravity neutral position during 3-4 
seconds when the patient’s maximal muscular force was overcome and the 
tested joint gave way, the “break method” (Bohannon, 1988). Muscle force 
was measured in study II and III.  
The reliability of handheld dynamometry has shown to be excellent in test-
retest with ICC2,2 values (using mean values of two measurements) between 
0.97-1.00 and a coefficient of variation (CV%) between 3.0%-5.3% in lower 
limbs (Wang et al., 2002), and in intra-rater reliability with ICC >0.91 in all 
measured muscle groups (Merlini et al., 2002, Visser et al., 2003). The inter-
rater reliability has shown varying results, ICC’s from 0.69-0.98, with lower 
ICC’s especially in the strong muscles; i.e. knee extensors (ICC 0.88) and 
ankle dorsiflexors (ICC 0.69) (Merlini et al., 2002). Reference values of 
muscle force in newton from two sources were utilised (Bäckman et al., 
1995, Phillips et al., 2000). 
3.4.2 Timed 10-m walk 
10-m COM and 10-m MAX 
With a still-standing start the patients walked in a self-selected comfortable 
speed (10-m COM) and in maximum speed (10-m MAX) a straightforward 
walk 10 meters in a long corridor with even surface towards a target 2.5 m 
beyond the 10 m mark. The examiner was standing by the 10 m mark with a 
stopwatch. At the comfortable speed the timekeeping started as the patients 
moved forward from the starting point, after the examiner had said “Are you 
ready? Then you can start walking”. At the maximum speed the instructions 
were to start at the word “Go” (in the starting phrase “Ready-Steady-Go!”) 
and then walk as fast as possible without running or risking stumbling. At the 
word “Go” the timekeeping started. In both cases the timekeeping ended as 
the trunk passed the 10 m mark. Hence acceleration was included but not 
deceleration (Wade et al., 1987, Bohannon, 1997, Watson, 2002, Bohannon 
and Williams Andrews, 2011).  
In the cross-sectional study (paper II) both comfortable and maximum gait 
speed was measured. As the reliability study (paper I) showed a preference 
for the maximum gait speed, the comfortable gait speed was abandoned and 
for that reason not measured at the three and five years assessments (paper 
III). 
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3.4.3 Performance-based measures of functional 
balance skills 
Our experience of physical difficulties in patients with DM1 guided our 
choice of functional balance tests to make it easier to complete as well as the 
wish of feasibility in all kind of clinical settings, bearing in mind expense and 
technical aspects (Jarnlo, 2003).  
In study I, both static and dynamic balance tests were evaluated for 
reliability. The tests of postural control, which are not presented below, are 
described in detail in the Appendix to study I. They were: Standing with feet 
together, with eyes open; Standing on one leg (right and left), with eyes open 
and closed; Tandem stance, with eyes open and closed; Walking in a figure-
of-eight. 
Two performance-based measures of functional balance were, together with 
the timed walk, after the reliability study (paper I), included in study II and 
III: the TUG, (Podsiadlo and Richardson, 1991); and the Step test by Hill 
(Hill et al., 1996).  
Timed Up & Go 
In the present thesis the TUG was performed in its original manner: from 
sitting in an armchair (45 cm high) with the hands on the arms of the chair, 
the patient rose and walked in a comfortable and safe pace to a mark 3 m in 
front of the armchair, turned, went back and sat down (Podsiadlo and 
Richardson, 1991). Timekeeping started as the patient’s back left the 
backrest, and ended as the buttocks reached the seat. The TUG was always 
done twice; the second performance was recorded. Inter-rater, intra-rater and 
intra-session reliability is high in TUG, with ICC’s of 0.90-0.99 (Norén et al., 
2001, Steffen et al., 2002, Wang et al., 2009). Smallest real difference was 
shown to be 1.1 second in community-dwelling elderly (Wang et al., 2009).  
Step test 
The Step test by Hill was performed with a low block (height 8 cm) as 
recommended in the original paper (Hill et al., 1996). The starting position 
was unsupported standing with parallel feet placed 5 cm behind the block 
(8x40x40 cm). The patient was requested to place the foot fully up onto the 
block and then return it fully back to the floor as many times as possible in 
15 seconds. Any side step or other disruption of the postural control would 
end the test and in that case only the completed steps up to that point were 
recorded. Both the right and the left leg were tested, after practice. The Step 
test has shown relative reliability, ICC >0.90 in healthy older subjects, and 
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significant correlations with the functional reach test, gait velocity and stride 
length (Hill et al., 1996). It has also shown high responsiveness, the 
Standardised response measure (the average change score over a set period of 
time/SD of that change) showed 0.92-0.95 in hemiplegic patients (Bernhardt 
et al., 1998).  
3.4.4 Patient reported outcome measures 
In study II and III the patients filled in questionnaires of balance confidence 
and walking difficulties as well as answered semi-structured questions on 
falls. All individuals got support from the examiner with reading, writing and 
explanation of the questionnaires, if needed.  
The Activities-specific Balance Confidence scale 
The ABC scale (Powell and Myers, 1995, Myers et al., 1996, Myers et al., 
1998) was used to assess the patients’ subjective perception of their balance 
self-efficacy. The scale consists of 16 indoor and outdoor non-hazardous 
activity items, requiring transferring, bending, reaching or walking. Each 
item is rated on a 0-100 scale of confidence after the question “How 
confident are you that you can maintain balance and remain steady, when 
doing (the specific activity)?” Responses range from no confidence at all (0) 
to full confidence (100) in maintaining balance. The mean of the 16 items is 
used as a sum score of balance confidence.  
The ABC scale has shown high stability over time (r=0.92, p<0.001), high 
internal consistency (Cronbach's alpha 0.96), good scalability (the coefficient 
of scalability, H=0.59, strong cumulative scale) and a good convergent and 
criterion validity (Powell and Myers, 1995). The ABC has also shown 
concurrent validity with the SAFE (Survey of Activities and Fear of Falling 
in the Elderly) worry scale, Pearson’s correlation coefficient r showed -0.65, 
p<0.001, a higher score on worry implied a lower ABC score. A lower ABC 
score correlated significantly with older age, slower gait speed, lower Berg’s 
Balance Test score, longer TUG time, greater activity restriction, more falls 
within the previous year, greater number of chronic illnesses and assistive 
devices (Talley et al., 2008). It has also been used in Sweden in studies with 
stroke patients and in dizzy patients (Jarlsäter and Mattsson, 2003, Forsberg 
and Nilsagard, 2013). A healthy elderly population with high mobility had a 
mean score 80.9 in the original study, whereas the elderly with low mobility 
scored 68.4 (Powell and Myers, 1995, Myers et al., 1998). We performed a 
pilot interview study that supported the relevance of the activity items in the 
patients with DM1. 
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Self-reported walking index 
The RW-index consists of five questions regarding perceived imbalance and 
difficulties during indoor and outdoor walking, and use of walking aids. The 
possible scores in three questions are 1 or 2, the other two questions have 
possible scores 1, 2 or 3. Thus the potential sum score is 5 to 12, where 12 
show no subjective walking difficulties, and 5 means large subjective 
walking difficulties including use of walking aids indoors. When use of 
walking aids was confirmed, the patients in our study were also asked to 
report what type of aids they used, e.g. ankle-foot orthoses and walking 
sticks.  
The RW-index has shown concurrent validity with clinical tests and had the 
highest correlation with comfortable walking speed (r=0.62), Timed Up & 
Go (r=-0.59), and walking in a figure of eight (r=-0.59) (Bergland et al., 
2002). The above mentioned pilot interview study also supported the 
relevance of the RW-index items in the patients with DM1. 
Semi-structured questions on falls 
Lastly, the examiner asked semi-structured questions on the occurrence of 
falls: During the previous year, how many unintentional falls have you 
experienced? How did it happen? Did the falls result in any injuries? Did you 
need any medical care? The patients were also asked if they were afraid of 
falling (yes/no) and if they avoided activities due to fear of falling (yes/no). If 
so, the activities were defined. 
If the number of falls were too many to actually remember, some memory 
cues were provided to assist the patient in estimating number of falls based 
on incidents during the last week and month.  
3.5 Analysis of the data 
Study I 
The patients were assessed on three occasions with one week in between. 
The relative reliability and the absolute variation were estimated. To control 
for any systematic main effects between the three occasions, an analysis of 
variance with repeated measures was performed. As a significant main effect 
was detected a further analysis of the levels was performed. 
Study II 
Data were analysed for the whole group and divided in subgroups. The whole 
group was compared with available reference data from a healthy reference 
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group and from published reference values (Bäckman et al., 1995, Phillips et 
al., 2000). The division in subgroups were in one part of the analysis patients 
with MIRS 1-3 and patients with MIRS 4-5; on the other part the group was 
divided in genders. For estimation of bi-variate correlation between falls and 
other variables the Spearman’s rank correlation was used. The number of 
falls had a skewed distribution, and therefore the variable was divided into 
three ordered categories of “fall groups”, namely 0-2, 3-6, and ≥ 7 falls per 
year. Ordinal regression modelling was used to analyse the odds ratio for 
factors associated with the underlying ordered structure among categories. 
Study III 
At least two visits per patient were considered necessary to include the 
patient in the analyses of natural disease course progression. When data was 
missing at the five-year assessment the missing values were substituted with 
the values from the three-year assessment, “last value carried forward”. The 
changes were analysed within the whole group (paired data) and for 
differences between groups (males and females).  
3.5.1 Statistical analysis 
An expert biostatistician was engaged as a consultant during all parts of the 
studies.  
Mean and standard deviation (SD) and 95% confidence interval (CI 95%) 
were presented in continuous data; for ordinal or skewed data the non-
parametric statistics was applied, median and quartiles (Q1;Q3) or minimum 
and maximum values. Dichotomous data were presented with number and 
percent.  
To analyse the relative reliability, the intraclass correlation coefficient ICC2,1 
(two-way repeated measures analysis of variance) was used in study I (Weir, 
2005). Measures of absolute variation were estimated using the standard 
error of the measurement (SEM), the repeatability, and the measurement 
error (ME) (Bland and Altman, 1996, 1999). To investigate any confounding 
effects between the three occasions, the analysis of variance (ANOVA) with 
repeated measures was used together with F-test of significance. If a 
confounding effect was detected a further analysis of the levels was 
performed with paired t-tests (paper I). The calculation of smallest real 
difference (SRD) is algebraically similar to the limits of agreement described 
by Bland & Altman, also called ‘repeatability’ (Bland and Altman, 1986). 
Lastly, in this thesis, SRD% was calculated by dividing SRD by the mean of 
the test results, multiplied by 100 (Beckerman et al., 2001). 
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In study II the differences between groups were analysed with Student’s t-
test. Bi-variate correlation was estimated using the Spearman’s rank 
correlation coefficient to explore correlations between the number of falls 
and the other variables: muscle force and functional balance skills; and also 
between the different dynamic balance tests and muscle force. Ordinal 
regression was used to analyse the odds ratio for factors associated with the 
underlying ordered structure among categories. Thus, the falls were divided 
into three ordered categories “fall groups”, which were set to 0-2, 3-6 and ≥7 
falls last year. The dependent variable “risk of falls” with these three 
categories was then analysed for factors of importance. First uni-variate, and 
then multi-variate analyses were performed to find the two most important 
factors (paper II). 
In study III, differences over time between groups in continuous data were 
analysed: with the Wilcoxon signed rank test for paired data; and the Mann-
Whitney U-test for unpaired differences (men and women). For analysis of 
ordered categorical data or dichotomised variables the Sign test was used for 
comparisons over time, and Mantel-Haenszel χ2 Exact test between groups 
(paper III).  
All significance tests were two-sided at the 5% significance level. 
Calculations were made in SPSS®, Statistics, up to v20 (IBM, USA) and SAS 
software, Version 9. 
3.6 Ethical approval 
According to the Declaration of Helsinki the individuals participated 
voluntarily after verbal and written information, and a written consent to 
participate in the study was obtained. The participants knew they could 
refuse further participation without any impact on further treatment. The 
Regional Ethical Review Board in Gothenburg, Sweden approved the study 
(Dnr 248-06 and Dnr 601-11). 
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4 RESULTS 
The baseline characteristics of the patients in each study are shown in Table 
4.  
Table 4. Characteristics of the patients involved in studies I-III, at baseline. 
Mean (SD) and range are presented in continuous data for age (in years), 
BMI (in kg/m2) and 10-m MAX (in seconds). Distribution in MIRS grades is 
shown in percent. 
  Study I 
N=10 
Study II 
N=51 
Study III 
N=43 
Sex   6M/4F 20M/31F 18M/25F 
Age  
  
43 (10.7) 
28-60 
41 (9.7) 
20-60 
41 (9.1) 
23-60 
BMI  
  
23.4 (4.0) 
18.3-32.1 
25 (5.4) a 
17.1-37.5 
24.4 (4.8) b 
17.2-37.5 
MIRS 
grade 
1 
2 
3 
4 
5 
0 (0%) 
0 (0%) 
0 (0%) 
8 (80%) 
2 (20%) 
2 (4%) 
1 (2%) 
16 (31%) 
28 (55%) 
4 (8%) 
0 (0%) 
0 (0%) 
16 (37%) 
24 (56%) 
3 (7%) 
10-m MAX  
 
7.5 (1.4) 
5.3-9.3 
8.3 (5.3) 
4.6-37 
7.5 (2.4) 
4.6-16.9 
Abbreviations: BMI, body mass index; MIRS, muscular impairment rating scale; 10-m MAX, 
10 meters Timed walk in maximum pace. 
a BMI <18.5, n=4; BMI 30-35, n=6; BMI >35, n=4  
b BMI <18.5, n=3; BMI 30-35, n=6; BMI >35, n=1  
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4.1 Study I 
Ten patients with DM1, six men and four women, mean (SD) age 43 (10.7) 
years, came at three occasions for repeated measurements, with one week in 
between each occasion. Most of the patients were classified as MIRS 4 
(80%), and none was classified as MIRS 1-3 (paper I).  
Timed 10-m walk 
Timed 10-m walk showed high relative reliability with only small differences 
between comfortable and maximum pace, see Table 5, and the within-subject 
standard deviation was small in both, SEM 0.6 and 0.4. A post hoc paired t-
test showed a systematic difference with a small effect size between occasion 
1 and occasion 2 in the comfortable pace, Cohen’s delta 0.28, and between 
occasion 2 and 3, Cohen’s delta 0.21. There was no (confounding) main 
effect between occasions in the 10-m walk in maximum pace. 
Static balance tests 
It was possible for all still-standing open-eye tests (Feet Together, One Leg 
Stance, Tandem Stance) to be performed at all occasions by all patients. One 
Leg and Tandem Stance showed good to high relative test-retest reliability 
ICC2,1 0.87-0.98. “Feet Together” lacked relative reliability due to a ceiling 
effect, all patients but one could perform the test full-time – 60 seconds (ICC 
0.31). There was great variability between occasions in the absolute variation 
values (SEM, repeatability and ME).  
Dynamic balance tests 
It was possible for all performance-based measures of functional balance 
skills (TUG, Step test and Walking in a Figure-of-Eight) to be performed at 
all occasions by all patients. The ICC2,1 showed good to high relative 
reliability, Table 5. The variability, as measured by SEM, repeatability and 
ME, was much less as compared to the static test. Walking in a Figure-of-
Eight showed a large standard deviation. In the Step test a systematic 
difference between occasion one and occasion two for the left-foot steps was 
shown, indicating a learning effect. Smallest real difference % (SRD%) is 
shown in Table 5.  
  
34
Force, falls and fear of falls in myotonic dystrophy type 1 
34 
4.1 Study I 
Ten patients with DM1, six men and four women, mean (SD) age 43 (10.7) 
years, came at three occasions for repeated measurements, with one week in 
between each occasion. Most of the patients were classified as MIRS 4 
(80%), and none was classified as MIRS 1-3 (paper I).  
Timed 10-m walk 
Timed 10-m walk showed high relative reliability with only small differences 
between comfortable and maximum pace, see Table 5, and the within-subject 
standard deviation was small in both, SEM 0.6 and 0.4. A post hoc paired t-
test showed a systematic difference with a small effect size between occasion 
1 and occasion 2 in the comfortable pace, Cohen’s delta 0.28, and between 
occasion 2 and 3, Cohen’s delta 0.21. There was no (confounding) main 
effect between occasions in the 10-m walk in maximum pace. 
Static balance tests 
It was possible for all still-standing open-eye tests (Feet Together, One Leg 
Stance, Tandem Stance) to be performed at all occasions by all patients. One 
Leg and Tandem Stance showed good to high relative test-retest reliability 
ICC2,1 0.87-0.98. “Feet Together” lacked relative reliability due to a ceiling 
effect, all patients but one could perform the test full-time – 60 seconds (ICC 
0.31). There was great variability between occasions in the absolute variation 
values (SEM, repeatability and ME).  
Dynamic balance tests 
It was possible for all performance-based measures of functional balance 
skills (TUG, Step test and Walking in a Figure-of-Eight) to be performed at 
all occasions by all patients. The ICC2,1 showed good to high relative 
reliability, Table 5. The variability, as measured by SEM, repeatability and 
ME, was much less as compared to the static test. Walking in a Figure-of-
Eight showed a large standard deviation. In the Step test a systematic 
difference between occasion one and occasion two for the left-foot steps was 
shown, indicating a learning effect. Smallest real difference % (SRD%) is 
shown in Table 5.  
  
34
Elisabet Hammarén 
 
Table 5. ICC, Repeatability and SRD% for gait and balance tests; OLS with 
eyes open, only right side. 
 10-m 
COM 
10-m 
MAX 
TUG STEP OLS (EO) 
ICC2.1 0.91 0.94 0.83 0.88 0.95 
Repeatability 1.8 sec 1.0 sec 1.9 sec 3.9 steps 8.4 sec 
SRD% 18% 13% 19% 28% 78% 
Abbreviations: OLS (EO), One leg stance (eyes open); SRD, smallest real difference.  
4.2 Study II 
Fifty-one patients with DM1, 20 men and 31 women, mean (SD) age 41 (9.7) 
years participated in the cross-sectional study. Thirty-two patients had not 
only distal muscle weakness, but also proximal weakness to a lower or higher 
degree, equivalent to MIRS grades 4 or 5. The remaining 19 patients had less 
weakness, equivalent to MIRS grade 1-3. 
Reference values 
Altogether 220 individuals (male/female 111/109) 20-59 years old, mean 
(SD) 37 (11.1) years, contributed to the reference data. Their body mass 
index (BMI) was mean (SD) 24 (3.6). The main results are presented in 
Table 6. The specific reference data for Timed walk, Timed Up & Go and 
Step test for each gender and age decade are presented in Paper I, Table 1. 
Table 6. Reference values for the reference group as a whole, n=220. In 
seconds and steps. 
 10-m COM 10-m MAX TUG STEP 
Mean 6.6 4.7 7.5 21.2 
CI95% 6.54-6.74 4.66-4.82 7.40-7.69 20.9-21.5 
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4.2.1 Comparisons 
Comparison with reference group  
A comparison between the patients with DM1 and the reference group was 
made using the specific age- and gender related mean values as matched 
data, Table 7. The Student’s t-test was used to analyse differences in 
continuous data. The difference between the patients with DM1 and the 
reference group in the number of falls, was analysed with χ2-test. There was a 
statistically significant difference (p<0.001) between the patients with DM1 
and the reference group in all tests as well as in number of falls.  
Table 7. Comparison between patients with DM1 and data from the 
reference group, analysis of difference with Student’s t-test (P value). Mean 
(SD) for continuous data. Median and quartiles (1;3) for number of falls. The 
falls were dichotomised in ‘0-2’ and ‘3 or more’ falls. 
 DM1 Reference group P value 
10-m COM 10.5 (1.4) 6.6 (0.2) <0.001 
10-m MAX 8.3 (1.5) 4.8 (0.2) <0.001 
TUG 10.4 (1.2) 7.6 (0.3) <0.001 
STEP 13 (1.6) 21 (1.2) <0.001 
Number of falls  1 (0;4.5) 0 (0;0) <0.001 
 
Comparison of isometric muscle force between patients 
with DM1 and reference values  
A comparison between the patients with DM1 and age- and gender related 
reference values of isometric muscle force from published reference studies 
was made (Bäckman et al., 1995, Phillips et al., 2000). All muscle force 
means of the patients with DM1 were decreased in relation to the expected 
force, Table 8. The relative force (the force compared to reference values) 
was lowest for the whole group in the ankle dorsiflexors and the knee flexors, 
52% and 53%, respectively.  
Comparison between genders 
A gender subgroup analysis was performed showing that the males were in 
absolute numbers stronger than females in hip flexors and knee extensors, 
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and no gender difference was shown in the knee flexor force, Table 8. 
However, in the ankle dorsiflexors the males were weaker than the females; 
the males had median 72 N, vs. 174 N for the females (p=0.033). In the 
analysis of force in relation to reference values, the males’ relative force was 
lower compared to females. The relatively weakest muscle group in men was 
the ankle dorsiflexors (27%). Moreover, in relative figures the males were 
weaker than the females in the knee flexors (46% vs. 58%), which were the 
weakest muscle group in the females, Table 8.  
In the dynamic balance tests there was a gender difference only in the 
number of steps, females had median 14 and males median 11 steps, 
p=0.008. No gender differences were shown in the Timed 10-m walk tests.  
 
Table 8. Results of force measurements (newton) in all patients with DM1, 
and by gender. The relative figures is the force compared to reference values. 
Mean (SD) or median (first quartile; third quartile) is presented. Analysis of 
difference in absolute muscle force between males and females was 
performed with Student’s t-test for independent groups (P value); Mann-
Whitney U test was used for the ankle dorsiflexors as the data was skewed. 
 
All 
N=51 
Males 
N=20 
Females 
N=31 P value 
Hip flexors a 85% 191 (44) 78% 
155 (31) 
89% 0.001 
Knee extensors b 86% 317 (126) 77% 
252 (61) 
92% 0.016 
Knee flexors b 53% 104 (44) 46% 97 (26) 58% 0.474 
Ankle 
dorsiflexors a 52% 
72 (44;125) 
27% 
174 (74;201) 
76% 0.033 
a (Phillips et al., 2000)  b (Bäckman et al., 1995) 
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Comparison between MIRS subgroups 
The data from the patients with DM1 was divided into two groups for 
analysis of differences between the weaker patients (MIRS 4-5) and the less 
muscular impaired patients (MIRS 1-3). There was a statistically significant 
difference between the weaker and the stronger patients in all compared 
measures, the least significance (p=0.014) was shown in the number of falls, 
median 3 vs. 0 falls, Table 9. More men were classified to MIRS 4-5. 
Table 9. Comparison between patients with muscular impairment: MIRS 1-3 
and 4-5. Student’s t-test and Chi2 are used for analyses of differences. Mean 
(SD) or median (first quartile; third quartile) is presented, as well as number 
(%). 
 MIRS 1-3 
(n=19) 
MIRS 4-5 
(n=32) 
P value 
Sex, χ2 3M/16F 17M/15F <0.001 
Ankle dorsiflexors 200 (184;225) 61.6 (43;96) <0.001 
10-m COM 8.1 (2.1) 12 (5.7) 0.001 
10-m MAX 6.1 (1.3) 9.7 (6.3) <0.001 
TUG 8.6 (2.1) 11.4 (5.0) 0.007 
STEP 17.1 (3.9) 10.5 85-1) <0.001 
ABC scale 91 (83;96) 62 (38;77) <0.001 
Number of falls, χ2 0 (0;1.5) 3 (0;6) 0.014 
Fear for falls, n (%), χ2 3 (16%) 18 (56%) 0.004 
Avoids activities due to fear 
for falls n (%), χ2 
3 (16%) 20 (59%) 0.001 
 
4.2.2 Factors of importance  
Factors of importance for functional balance impairment 
Each muscle group showed a statistically significant correlation (rs = 0.39 to -
0.65, p between 0.004 and <0.001) with the different dynamic balance tests 
38
Force, falls and fear of falls in myotonic dystrophy type 1 
38 
Comparison between MIRS subgroups 
The data from the patients with DM1 was divided into two groups for 
analysis of differences between the weaker patients (MIRS 4-5) and the less 
muscular impaired patients (MIRS 1-3). There was a statistically significant 
difference between the weaker and the stronger patients in all compared 
measures, the least significance (p=0.014) was shown in the number of falls, 
median 3 vs. 0 falls, Table 9. More men were classified to MIRS 4-5. 
Table 9. Comparison between patients with muscular impairment: MIRS 1-3 
and 4-5. Student’s t-test and Chi2 are used for analyses of differences. Mean 
(SD) or median (first quartile; third quartile) is presented, as well as number 
(%). 
 MIRS 1-3 
(n=19) 
MIRS 4-5 
(n=32) 
P value 
Sex, χ2 3M/16F 17M/15F <0.001 
Ankle dorsiflexors 200 (184;225) 61.6 (43;96) <0.001 
10-m COM 8.1 (2.1) 12 (5.7) 0.001 
10-m MAX 6.1 (1.3) 9.7 (6.3) <0.001 
TUG 8.6 (2.1) 11.4 (5.0) 0.007 
STEP 17.1 (3.9) 10.5 85-1) <0.001 
ABC scale 91 (83;96) 62 (38;77) <0.001 
Number of falls, χ2 0 (0;1.5) 3 (0;6) 0.014 
Fear for falls, n (%), χ2 3 (16%) 18 (56%) 0.004 
Avoids activities due to fear 
for falls n (%), χ2 
3 (16%) 20 (59%) 0.001 
 
4.2.2 Factors of importance  
Factors of importance for functional balance impairment 
Each muscle group showed a statistically significant correlation (rs = 0.39 to -
0.65, p between 0.004 and <0.001) with the different dynamic balance tests 
38
Elisabet Hammarén 
 
and timed 10-m walk, as factors of importance for functional balance 
impairment. The gait test and single leg muscle group with the greatest 
correlation was 10-m MAX and ankle dorsiflexors, rs = -0.65 (p<0.001). The 
10-m COM and total muscle force showed rs = -0.71 (p=0.001). Knee flexor 
force was the most important single muscle group for TUG, rs = -0.61, 
p<0.001; and ankle dorsiflexor force for Step test, rs = 0.56, p<0.001. 
Factors of importance for falls 
Factors of importance for frequent falls showed to be the balance confidence 
assessed with ABC score, the ankle dorsiflexor muscle force and a larger 
time-difference between comfortable and maximum walking speed in 10-m 
walk (paper II).  
A moderate negative correlation between number of falls and ankle 
dorsiflexor force (-0.38, p=0.007), and Step test (-0.36, p=0.01) was shown. 
Further, a moderate positive correlation was shown between falls and TUG 
(0.39, p=0.005). There was a strong negative correlation between number of 
falls and patient reported balance confidence in ABC, rs -0.52, and p <0.001. 
In the results of the uni-variate ordinal regression analysis an augmented risk 
of falling with 49% at a decrease of 10 units in the ABC scale was shown. 
The multi-variate analysis detected that a decrease of ten newton in ankle 
dorsiflexor force would infer 15% increased fall risk, and an increase in time-
difference with one second between comfortable and maximum walking 
speed, measured over 10 meters, would increase the fall risk with 42%. 
4.3 Study III 
Forty-six patients with DM1 from the cross-sectional study were included at 
baseline in the longitudinal study. After three dropouts, data from 43 patients 
(18 men/25 women, mean (SD) 41 (9.1) years of age) were available for 
analysis at the five-year assessment (Y5). The results were analysed in total 
and by gender. Thirteen patients had worsened in MIRS-grade, and the 
change was statistically significant in both gender subgroups. At Y5 the 
mean (range) in BMI was 25.6 (17.5-39.4); n=9 had BMI 30-35; all other 
numbers were the same. The proportion of patients with BMI 30-35 had 
increased from 14% to 21%. 
Isometric muscle force 
A statistically significant force decrease was shown in all four examined leg 
muscle groups, mean change -8 to -15 N, p value between <0.001 and 0.017. 
For males, all muscle groups showed an absolute force decrease of statistical 
significance; for females this was only seen in the hip flexors (p<0.001). In 
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absolute figures the change was significantly different between males and 
females in knee extensors and knee flexors. Analysis of change in relation to 
baseline force, however, showed a significant difference also in the ankle 
dorsiflexors; for the whole group the relative change in ankle dorsiflexors 
was mean -12%, although for males the relative change was -22% vs. -7% 
for the females, Table 10.  
Table 10. Relative change in muscle force for all patients with DM1, and by 
gender. Mann-Whitney U test is used for analysis of difference between 
genders. 
 All Males Females P value 
Hip flexors -7%  -7%  -7%  0.82 
Knee extensors -6%  -11%  -1%  0.028 
Knee flexors -8%  -13%  -4%  0.013 
Ankle dorsiflexors -12%  -22%  -7%  0.034 
 
Performance–based measures of functional balance 
All dynamic balance tests and gait showed statistically significant 
deteriorations, with p<0.001, Table 11. The timed 10-m walk (10-m MAX) 
showed a mean time increase of 1.8 seconds at Y5. The Timed Up & Go 
showed a mean increase of 2.4 seconds, and Step test showed a mean 
decrease of 2.6 steps compared to baseline, Table 11. No differences between 
genders were shown in the tests of 10-meter walk and functional balance. 
Patient reported outcome measures 
There was a minor but statistically significant reduction in ABC score, mean 
(SD) score change -7 (18), p=0.024 for the whole group. The deterioration 
was larger for males, mean (SD) score change -10 (19), p= 0.042, the 
deterioration for females did not reach statistical significance.  
The RW-index also showed deterioration, 56% got worse, p=0.003, with no 
statistically significant difference between genders. The number of falls, as 
expressed in mean (SD), did not change. However, the proportion of patients 
experiencing at least one fall had increased from 58% to 77%. All males 
(100%) had fallen during the previous year, a statistically significant change, 
compared with 67% at baseline (p =0.031). Twenty-one patients (49%) had 
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fallen three or more times within the previous year, as compared to only 14 
(33%) at baseline. The number of patients who needed medical care was 
increased, 42% had reported need for care after falls at Y5 vs. 16% at 
baseline, p=0.013. Fear of falling was reported by 63% at Y5, compared to 
37% at baseline, p=0.007. 
Table 11. Timed 10-m walk and dynamic balance tests at baseline and year 
five (Y5). P value for change. N=43 
Measures  Baseline Y5 P value 
10-m MAX 
(seconds) 
Mean (SD) 
Min-Max 
7.5 (2.4) 
4.6 – 16.9 
9.3 (4.3) 
5.1 – 24.2 
<0.001 
Timed Up&Go 
(seconds) 
Mean (SD) 
Min-Max 
9.6 (2.4) 
6.5 – 17.5 
12.0 (5.4) 
7.0 – 34.4 
<0.001 
Step test 
(steps) 
Mean (SD) 
Min-Max 
13.3 (5.4) 
0 – 23.5 
10.7 (6.5) 
0 – 22.5 
<0.001 
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5 DISCUSSION 
The most important finding in this thesis is the increasing number of harmful 
injuries, which the patients had experienced after falls. Further, we have 
linked loss of muscle force in lower extremities with decrease in dynamic 
balance. Lastly we also found a gender difference; there was a more 
prominent decrease in muscle strength in males after five years. We do not 
have data explaining the reason for this difference. 
5.1 Methodological discussion 
Measuring muscle force 
The isometric muscle force measurements of the patients with DM1 were 
compared with reference data (Bäckman et al., 1995, Phillips et al., 2000). A 
limitation with the relative values when comparing with reference data is the 
reliability limits of the reference material. We did not collect this reference 
material ourselves; we had to rely on published data. A weakness in the 
method of measuring isometric muscle force by handheld dynamometer is 
the difficulty for an examiner to reliably measure strong muscles. This could 
result in reference values that are falsely too low in e.g. ankle dorsiflexors 
and knee extensors, at least in the case of the data for males. To decrease the 
risk of falsely reporting too weak a muscle force in strong muscles in our 
study, we utilised the wall as support, if needed. In the case a patient 
nevertheless was too strong, the break method could not be used, and the 
force was measured without the break. It is not believed that the break 
method could elicit a stretch-evoked response, but the force generated during 
muscle lengthening is shown to exceed maximum isometric force (Webber 
and Kriellaars, 1997).  
An advantage of this longitudinal study is that the same examiner performed 
all measurements. The variability in readings obtained by handheld 
dynamometry can be kept to a minimum when only one examiner is used 
(Goonetilleke et al., 1994).  
Measuring gait 
The timed 10-m walk should not be regarded as a balance test, as it is a gait 
test. But the gait will be secondarily affected if the postural stability is 
impaired. This makes it useful as a performance-based measure of functional 
balance together with the Step test and TUG (Jarnlo, 2003).  
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We chose to measure time to walk 10 meters from a still-standing start, a 
straight forward walk of 10 meters in a long corridor, with a flying finish. 
This choice was made as we wanted to include the patients’ sometimes slow 
start. The patients walked towards a target 2.5 meters beyond the 10-meter 
point. Hence acceleration was included but not deceleration. Our intention 
was to mimic a distance and a situation of a (large) zebra crossing. Reference 
values for gait speed (in m/sec or cm/sec) where no acceleration or 
deceleration is included are published, but were considered less suitable for 
us (Öberg et al., 1993, Bohannon, 2008, Bohannon and Williams Andrews, 
2011).  
Assessment of postural control 
There are three main approaches to clinical balance assessments: a functional 
approach to identify fall risk; a systems approach to determine the underlying 
cause; and quantitative posturography (Horak, 1997).  
The systems approach to determine an organ dysfunction or an underlying 
diagnosis, e.g. cerebellar dysfunction or sensory deficiency, was not within 
the scope of this thesis. The weakness in distal leg muscles, characteristic for 
patients with DM1, is thoroughly studied as one risk factor for falls among 
several others, and in combination the fall risk increases (Rubenstein, 2006). 
It has been shown that muscle strength reduction in nursing home residents 
with a history of falls was more severe, compared with those with no history 
of falls. The difference was most pronounced in the ankle dorsiflexors; 
(isokinetic) muscle torque was one tenth that of controls (Fukagawa et al., 
1995). 
Laboratory centre of gravity measurements with force platforms, giving a 
picture of how the centre of mass has moved over the base of support during 
different tests, have increasingly been used in postural control research. The 
use of force platforms in the clinic is not forecasted, and the laboratory 
setting was therefore rejected in investigations in the present thesis. 
We chose not to use the well-renowned Berg Balance Scale (Berg, 1989) 
since the BBS was believed to have ceiling effects in the younger, well 
functioning, DM1 population. Instead we chose performance-based measures 
of functional balance skills: 10-meter walk in maximum speed; Timed Up & 
Go; and Step test, as the DM1 patients are believed to fall (often after 
tripping) in walking and stepping situations. The reliability study (paper I) 
examined these dynamic and also static balance tests in the patients with 
DM1. The static tests were less test-retest stable than the dynamic, and were 
consequently rejected. The dynamic balance tests in this thesis were chosen 
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as items resembling balance requiring daily activities. The anticipatory 
postural control could be seen as a component in both dynamic tests as well 
as in the gait tests. 
Perceived balance confidence and walking ability 
Our choice of balance confidence measurement instrument stood between 
two at that time available questionnaires developed to measure “fear of 
falling” (FES) (Tinetti et al., 1990, Hellström and Lindmark, 1999) or 
“perceived confidence in keeping balance, when doing different activities” 
(ABC) (Powell and Myers, 1995). Both questionnaires were utilised in the 
cross-sectional study (paper II) but only the ABC data have been reported. 
Three main reasons contributed to the choice of ABC for the prospective 
study (paper III): 1) the questions of ABC were constructed in a positive 
way; 2) both ABC and FES included several activities at home, but the ABC 
included several activities in the community, versus only one in the FES. 
Further, we conducted a post hoc analysis after the cross-sectional study 
(paper II) which showed 3) large ceiling effects in the FES. Given the result 
of this analysis and that the studied patients with DM1 was between 20 to 60 
years of age, the ABC seemed to be the most suitable questionnaire.  
The RW-index has shown to be a statistically significant predictor for 
repeated falls: a sum score of eleven or less indicates a positive predictive 
value of 0.25 to fall two times or more during the next year. Nevertheless, the 
area under the resulting receiver-operating characteristic (ROC) curve was 
just 0.57, which is interpreted as a not so efficient classifier (Bergland et al., 
2002). It may be used in the health care system as a simple tool to identify 
people at increased risk of falling, but has a ceiling effect in a healthier 
population. 
Questionnaires with self-assessments in patients with DM1 are not easy to 
use for all patients, since reading may be impaired due to dyslexia, short-term 
memory may be impaired, as well as the ability to visualise a situation 
exemplified in a questionnaire (Gagnon et al., 2007b). Further, since writing 
may be difficult due to hand and finger weakness, questionnaires with 
multiple-choice question are preferred.  
The evaluation methods for number of falls recommended with use of 
diaries, calendars or postcards were not chosen in the present thesis. An 
accelerometer worn day after day for years was not a viable choice, for 
integrity reasons as well as for expected compliance difficulties. Despite the 
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obvious risk for retrospective recall error, the method used by us was half-
open questions at the assessment occasions.  
5.2 General discussion 
Reliability 
The results of the first study show that Timed Up & Go and the Step test are 
reliable and test-retest stable performance-based measures of functional 
balance skills, feasible to use in a DM1 population, after a practice round. 
Therefore these tests were used to evaluate balance skills in the patients with 
DM1, and not the still-standing tests, which showed a large discrepancy in 
the measures of absolute variation. To evaluate postural control in 
locomotion, Timed 10-meter walk in maximum speed is preferred before the 
comfortable speed, showing no confounding effect between times and low 
absolute variation together with high relative test-retest stability.  
Muscle force 
The patients with DM1 as a group were significantly weaker than published 
reference data in all muscles of the lower extremities that we studied. The 
more severely affected patients, classified as MIRS 4-5, were likewise 
weaker than the less affected, as expected.  
We found that there was a gender difference; females were relatively 
stronger than males in all muscle groups examined, compared to reference 
values, and in absolute numbers stronger than males in the ankle dorsiflexors. 
This was also reflected in the MIRS classification where 85% of the males 
had MIRS grade 4-5, vs. 48% of the females. The reason for this disparity is 
still to be investigated. 
The most affected muscle group in males with DM1 was the ankle 
dorsiflexors, where the relative muscle force was 27%, compared to expected 
values, in contrast to 76% in females. For females the knee flexors were the 
weakest, 58% of the expected value, but in males the strength was still lower, 
at 46%. In this study the upper limb muscle weakness was only taken into 
account for the MIRS classification, which doesn't give enough data to 
generalise the gender differences further. We do not know if there is also a 
gender difference in the upper extremities. 
After five years the deterioration in muscle force was significant for the 
whole group in all muscle groups. A gender subgroup analysis, though, 
revealed that the women had a statistically significant loss of muscle force 
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only in the hip flexors. In the long term, obviously, the progress in leg 
muscles was more prominent in the men. If this can be confirmed in 
additional studies it has to be taken into account in future therapeutic studies. 
Timed 10-m walk, TUG, Step test 
The first moments of walking and the Step test were very difficult for some 
individuals, as they had great difficulty to stand still before starting the tests. 
The use of the step strategy or the “changing base of support” strategy is 
normally used as a response to large perturbations but in these study patients 
this strategy showed up when trying to stand still. This might be evidence of 
a severely impaired postural control due to very weak distal muscles, the 
patients not being able to deal with any sway at all (Nashner, 1987).  
The timed 10-m walk was impaired, already showing an increased time in the 
less impaired patients with DM1 in the cross-sectional study (II). Patients 
with MIRS 1-3 had 83% of the speed in the reference group in 10mCOM, 8.1 
seconds vs. 6.6 seconds or 1.23 m/s vs.1.5 m/s, respectively. The patients 
with MIRS 4-5 walked slower, mean 12 seconds (0.83 m/s). A pedestrian 
speed of 1.22 to 1.4 m/s is needed to cross a street with traffic light in proper 
time (Lundgren-Lindquist et al., 1983, Langlois et al., 1997). 
The Step test requires stability in the supporting leg and anticipatory postural 
control in locomotion. It gives information on the functional balance skills, 
even if the patient fails to make one single step. The systematic difference 
between occasion one and occasion two for the left-foot steps in Step test 
indicated a learning effect. Thus, the mean of the right and the left steps was 
employed in the analysis to diminish the influence of such learning effect. 
The well-renowned TUG test has in this study shown its feasibility also in 
the patients with DM1. It examines different aspects of postural control, but 
primarily the anticipatory aspect, including elements like rising, turning and 
sitting down. The TUG test time could give support for possible fall risk as 
well as functional mobility. Unfortunately, we did not use the expanded dual-
task TUG, where the extra cognitive demand could further increase the 
discriminative value of the test (Hofheinz and Schusterschitz, 2010). 
We found a statistically significant decrease in the performance of timed 10-
m walk, TUG and the Step test after five years, both in the whole group and 
for males and females, respectively. This is interesting, as the females did not 
show as large force reductions. Could it be that the dynamic balance tests are 
more sensitive to changes? Could it be more important to follow these 
measures than the muscle force, at least in women? 
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Altogether, it seems important to use all three measurements to capture 
different aspects of the patients’ impairment.  
Falls, fear of falls and activity avoidance 
Muscle weakness has been shown to be an important risk factor for falls 
(Wiles et al., 2006, Horlings et al., 2008). Avoidance of activities for fear of 
falling has earlier been shown to increase with a greater number of falls 
(Yardley and Smith, 2002). People living in the community over the age of 
75 have, when asked, agreed to consequences of falling of 60% “I will be in 
pain” but also of 58% to “I will be embarrassed” and of 56% “I will feel 
foolish” (Yardley, 2003). It would be likely to presume that these fears are 
also common in patients with DM1. 
The patients classified with MIRS ≥ 4 reported a significantly larger number 
of falls, more fear of falling, and more avoidance of activities than the 
patients in the MIRS ≤ 3 group. 
The balance confidence was shown to be a measure reflecting the risks for 
frequent falls. The confidence is likely to diminish after experiencing 
repeated falls, it could be seen as self-evident, but it is satisfying to see that 
patients with DM1 are aware of their problems. A decrease in ankle 
dorsiflexor force diminishes the ground clearance capacity for the swing 
phase. This change in space between foot and ground increases the risk of 
stumbles and subsequent falls (paper II). The increased time-difference 
between comfortable and maximum walking speed shows a capacity of faster 
walking while the self-selected walking speed diminishes, which could be a 
sign of awareness of stumble risks. 
The number of patients who reported a fall within the previous year had 
increased by Y5. All men had fallen. The effects of the falls were worse. This 
could also be due to a decreased muscle strength in the elbow extensors or 
the neck flexors, which have been reported in other studies (Harper, 2001, 
Mathieu et al., 2001). Week elbow extensors namely will limit the possibility 
for the patient to protect their face, if falling forward; or to protect their 
head/neck if falling backwards with week neck flexors. 
Is it possible to prevent these falls? Could a “Nordic walking pole” or a cane 
help? The use of AFO’s in patients with DM1 has not yet been sufficiently 
evaluated. These questions remain to be answered. In the meantime it is 
necessary to follow the patients with MIRS grade ≥3 regularly, at least 
yearly. 
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Concurrent with these falls, 63% of the patients reported fear of falling and 
60% that they avoided activities due to fear of falling. Self-chosen activity 
restriction as a consequence of fear of falling, not necessarily preceded by an 
actual fall, is an independent predictor of decline in physical function in an 
elderly population (Deshpande et al., 2008). Feared consequences of falls are 
shown to be loss of functional independence and damage to identity (e.g. 
feelings of shame in embarrassing situations (Yardley and Smith, 2002). 
Avoiding of activities may in turn lead to a sedentary life with several known 
negative side effects, as an increase of cardio-metabolic risk factors, diabetes 
type II, obesity and depression. The number of patients with BMI ≥ 30	 had 
increased, which could be regarded as an indication of the accuracy of this 
assumption. This is information that has to be handled. The possibility to 
attend physiotherapists to exercise is limited; workouts with fun and easy 
programmes to music, like the “Friskis & Svettis Open Doors”, are requested 
(Kierkegaard et al., 2011a). Aquatic exercise in a group is another possible 
way of practising physical training. First and foremost a positive way of 
coaching these patients to regularly attend physical activities is 
recommended. However, there are several obstacles that ideally should be 
dealt with: proximity, affordability, compliance and motivation. 
Reference group 
The results of the reference material collection show that during 20-59 years 
of age the walking speed in Timed 10m-walk and the performance time of 
TUG is quite constant and remains at a similar level for both genders in a 
Swedish population. During the sixth decade the number of steps in the Step 
test dropped (-3 steps) in males, but remained the same as in the fifth decade 
in females. The reason for this is unknown. 
Postural control and age 
The response to unforeseen balance threats changes with age (Lin and 
Woollacott, 2002). Younger people use their ankle muscles to a higher extent 
than older people. Both stable and unstable older people use a hip-dominated 
strategy in response to perturbations in stance. Unstable older people also use 
alternative strategies, such as bending the knees or using the arms to give 
support (Shumway-Cook and Woollacott, 2007). With faster perturbations 
the stepping strategy was used in older people, but not in younger (Lin and 
Woollacott, 2002). Changes in the motor systems affecting postural control 
are shown to follow the natural ageing process, and these changes can 
contribute to an inability to maintain balance. Age-related changes in the 
systems of postural control includes muscle weakness, impaired timing of the 
muscles involved in response to instability, and limitations of the adaptive 
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movements in response to different tasks and changing environmental 
demands (Shumway-Cook and Woollacott, 2007). Postural stability 
diminishes with older age and this could account for the increasing 
occurrence of falls in older adults (70s, 80s). This in turn could be an effect 
of a slowing in the anticipation process. Temporally delayed activation of 
anterior postural muscles in unstable older adults was shown in a study. 
Older adults had a significantly longer onset latency compared to younger 
adults and a decreased strength in lower extremity muscles (Lin and 
Woollacott, 2002).  
If this occurs also in the DM1 patients with already weakened ankle muscles 
remains to be discovered, but a fact is that the step strategy is common in 
weaker patients with DM1 and in elderly people alike. In some ways the 
middle-aged patient with DM1 resembles an older person. Thus, it could be 
of interest to compare the findings in our cohort with research in older 
individuals.  
Limitations 
The muscle function aspect power has not been analysed in this thesis. It 
would be of great interest to investigate further the impact of muscle power 
on falls and postural control in DM1, as the “explosive strength” could yet be 
a more important factor than muscle force. 
The differences between men and women in this study could be caused by a 
selection bias, as the longitudinal study was not a population based study. 
However, the drop-out analysis shows similar disease duration, gender and 
age in both groups. 
There have been no evidence of other balance disturbances among the 
patients than those secondary to the muscle strength decline, but the present 
study has not analysed range of motion, deep sensibility, vision, cerebellar 
function or cognition. Aspects not covered by the tests used in this thesis are 
the reactive postural control, challenged in unforeseen perturbations; and the 
vestibular (Balatsouras et al., 2013), visual and somatosensory systems. 
The study of timed walk has not included the measure of stride length. This 
could be a limitation as a recent study on patients with spinal muscular 
atrophy has shown that stride length, but not strength, fatigue or other gait 
variables, was associated with falls (Montes et al., 2013).  
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Another limitation of this thesis is that the psycho-social aspects of the 
dynamic balance impairment and falls not have been covered. These aspects 
are also very important and could be the object of further investigations. 
5.3 Implications 
The gait and dynamic balance tests showed a substantial mean deterioration 
accompanied by an increase of the proportion of patients avoiding activities 
due to fear of falling. We find it imperative to follow this patient group 
continuously, ask them about falls and refer them to physiotherapy treatment 
and follow-up using tests of dynamic balance (TUG and Step test), timed 
walk and muscle strength measurements. Walking aids, orthoses and electric 
wheelchairs are devices that may enhance continued activity participation, 
Table 12.  
Table 12. Levels of disability and levels of intervention in DM1 in relation to 
ICF terminology. 
 Intervention Prevention 
Health 
condition 
 
No cure available for DM1 
 
Genetic counseling 
Health promotion 
Nutrition 
Impairments 
 
Medication 
Pacemaker  
Rehabilitation therapy 
Balance exercise  
Physical fitness exercise 
Prevention of development of 
further activity limitations 
 
Activity 
limitations 
 
Assistive devices 
Walking aids  
Ankle-foot orthoses 
Electric wheelchair 
Preventive rehabilitation 
Prevention of development of 
participation restrictions 
Participation 
restrictions 
Accommodation adaptions 
Public education 
Environmental change 
Employment strategies 
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It is notable that the progression of muscle weakness in the knee extensors, 
which are important for knee stability, was faster within the male group, and 
that all male patients had fallen in the previous year. Both males and females 
showed significant changes in the dynamic balance tests, but the 
deterioration in muscle strength was shown to be more severe in males. We 
thus recommend considering a more rigorous follow-up in patients with 
MIRS ≥3.  
The present study has broadened the possibilities of evaluating up-coming 
balance exercise therapy interventions, as well as other future studies in 
patients with DM1. As long as no cure exists the need for rehabilitation 
interventions and research will remain. This study will hopefully bring to the 
fore more research on postural control in patients with DM1, exercise studies 
aimed at preventing falls are strongly recommended. 
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CONCLUSIONS 
We have studied muscle force and functional balance skills through gait and 
dynamic balance tests; as well as patient reported balance confidence, 
walking ability and falls within patients with DM1 during a five-year period. 
The isometric muscle force and functional balance showed at the baseline 
assessment a moderate but statistically significant decrease compared to 
reference values (muscle force) and a reference group of healthy individuals 
(functional balance).  
These variables also showed a substantial mean deterioration after five years, 
accompanied by an increase of the proportion of patients avoiding activities 
due to fear of falling. The activity avoiding behaviour could be seen as a 
consequence of this decreasing muscle force and functional balance 
impairment.  
During the year prior to the five-year assessment all men had fallen. Males 
also showed a more prominent decrease in muscle force than females. We are 
inclined to believe that there is a gender difference in the progress of the 
impairment. 
After five years the falls, although they did not increase in numbers, included 
a larger proportion of the patients. These patients encountered more severe 
injuries, which led to a higher degree of need for medical care services.  
We find it imperative to follow this patient group continuously, ask them 
about falls and refer them to rehabilitation treatment and follow-up. Walking 
aids, orthoses and electric wheelchairs are devices that may enhance 
continued participation in different activities. 
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6 FUTURE PERSPECTIVES 
Further studies are required to evaluate if rehabilitation interventions, 
including alternative balance strategies, in the long-term care of patients with 
DM1 could lead to a diminished rate of falls in the future. This could include 
a study on reactive and anticipatory postural control under computerised 
conditions. 
Additionally, studies to further confirm the gender difference in loss of 
muscle strength are required. 
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